Literature DB >> 16164033

Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth.

Gerben J van der Bij1, Steven J Oosterling, Sybren Meijer, Robert H J Beelen, Marjolein van Egmond.   

Abstract

Development of liver metastases is a frequent complication in the course of gastro-intestinal malignancies. After entering the liver via the portal circulation, blood-borne tumor cells that have been seeded from primary colorectal cancer, are first encountered by Kupffer cells (KC), which line the liver sinusoids. KC represent approximately 10% of all liver cells, and have the ability to kill tumor cells. As such, they may play an important intrinsic role in the protection against outgrowth of hepatic metastases. Furthermore, the cytotoxic function of KC is increased upon stimulation with various biological response modifiers, such as interferon-gamma, granulocyte macrophage-colony stimulating factor, antibodies and muramyl dipeptides. Therefore, enhancement of KC cytotoxic functions may represent an attractive treatment modality to prevent development of liver metastases in the clinical setting.

Entities:  

Mesh:

Year:  2005        PMID: 16164033     DOI: 10.1016/j.imbio.2005.05.020

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  Molecular Pathways: Targeting the Microenvironment of Liver Metastases.

Authors:  Simon Milette; Jason K Sicklick; Andrew M Lowy; Pnina Brodt
Journal:  Clin Cancer Res       Date:  2017-06-14       Impact factor: 12.531

2.  The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.

Authors:  Shu Wen Wen; Eleanor I Ager; Jaclyn Neo; Christopher Christophi
Journal:  Cancer Biol Ther       Date:  2013-06-17       Impact factor: 4.742

3.  Bimodal role of Kupffer cells during colorectal cancer liver metastasis.

Authors:  Shu Wen Wen; Eleanor I Ager; Christopher Christophi
Journal:  Cancer Biol Ther       Date:  2013-05-10       Impact factor: 4.742

4.  Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers.

Authors:  Ying Li; Hong Cao; Zhongxian Jiao; Suresh B Pakala; Divijendra Natha Reddy Sirigiri; Wenpin Li; Rakesh Kumar; Lopa Mishra
Journal:  Cancer Res       Date:  2010-10-01       Impact factor: 12.701

5.  Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases.

Authors:  N W Molla; M M Hassanain; Z Fadel; L M Boucher; A Madkhali; R M Altahan; E A Alrijraji; E B Simoneau; H Alamri; A Salman; Z Gao; P P Metrakos
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

6.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

Review 7.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  Gliotoxin causes apoptosis and necrosis of rat Kupffer cells in vitro and in vivo in the absence of oxidative stress: exacerbation by caspase and serine protease inhibition.

Authors:  Kristin Anselmi; Donna B Stolz; Michael Nalesnik; Simon C Watkins; Ravindra Kamath; Chandrashekhar R Gandhi
Journal:  J Hepatol       Date:  2007-04-05       Impact factor: 25.083

9.  Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.

Authors:  Mandy Gruijs; Rens Braster; Marije B Overdijk; Tessa Hellingman; Sandra Verploegen; Rianne Korthouwer; Berend J van der Wilk; Paul W H I Parren; Hans J van der Vliet; Marijn Bögels; Marjolein van Egmond
Journal:  J Oncol       Date:  2022-01-07       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.